LI

Investment firm

Lyell Immunopharma

Corporate VC

WebsiteLinkedIn pageCrunchbase profileSeattle·Washington·United States5known portfolio companies1person tracked9co-investors

Lyell Immunopharma is a corporate venture arm. The one team member on file is in Seattle, Washington, United States. The known portfolio counts 5 companies, including Eureka Therapeutics, Outpace Bio, Sonoma Biotherapeutics, Sonoma Pharmaceuticals and Cero Therapeutics.

Is Lyell Immunopharma a fit for your startup?

Paste your website. AI checks the fit and scores every other investor too.

Investment focus

Who to pitch at Lyell Immunopharma

Lyell Immunopharma portfolio companies (5)

  • Eureka Therapeutics
  • Outpace Bio
  • Sonoma Biotherapeutics
  • Sonoma Pharmaceuticals
  • Cero Therapeutics

Co-investors

Funds that share portfolio companies with Lyell Immunopharma.

Similar funds

Showing 20 of 100

About Lyell Immunopharma

The firm's listing covers sector Healthcare, and focus areas Biotech, Cell Therapy, Drug Discovery and Genomics; known deals cluster at Seed and Series A.

Tracy Ooi (Senior Principal Scientist) is listed as the contact to pitch at Lyell Immunopharma.

Lyell Immunopharma shares portfolio companies with 9 other investment firms, among them California Institute for Regenerative Medicine, Regeneron and Milky Way Ventures.

Frequently asked questions

What is Lyell Immunopharma?

Lyell Immunopharma is a corporate venture arm whose one person on file is in Seattle, Washington, United States, with a known portfolio of 5 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.

What does Lyell Immunopharma invest in?

Listed sectors include Healthcare; listed focus areas include Biotech, Cell Therapy, Drug Discovery and Genomics. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.

What stage does Lyell Immunopharma invest at?

The known deals of Lyell Immunopharma include Seed and Series A rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.

Who should I pitch at Lyell Immunopharma?

One person at Lyell Immunopharma is on file, listed as a contact for the firm, with their own profile page.

How do I contact Lyell Immunopharma?

Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The one person attached to the firm has their own page, which shows whether an address is on file for them.

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal